Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

WalterSmith922 Jul. 8 at 5:48 PM

$NREDF This is not the moment to get soft This is the moment to Buy the dip I’m holding $NRED.CSE because the bullish thesis still has multiple engines behind it The crowd always wants confirmation after the move I want exposure before the move becomes comfortable Buy the dip. Hold the line NFA. $INTC $NOK $PFE

0 · Reply

DoubleUpwithChuck Jul. 8 at 5:48 PM

$ELTP $GSK $MRNA $PFE https://elitepharma.com/ the correct website

0 · Reply

Micheal_Pothead Jul. 8 at 5:36 PM

$PFE just go red man..

0 · Reply

CapitalismUSA Jul. 8 at 5:36 PM

$ABUS $PFE Hey Pfizer crooks ……

0 · Reply

Micheal_Pothead Jul. 8 at 5:33 PM

$PFE the Nasdaq is green… Lol..

0 · Reply

TheUnmaker Jul. 8 at 5:25 PM

$TNXP $SLS $PFE $GALT

1 · Reply

DivvyInvestor Jul. 8 at 5:06 PM

$PFE I Wanna Get Back In PFE.. How Bout $23.70 Again ? There...........

0 · Reply

DivvyInvestor Jul. 8 at 5:04 PM

$PFE I'd LOVE To Re Establish My Position Of 52,000 Shares Again At $23.70, Where I Bought, Monday. SO PFE...........

0 · Reply

breakawayrider Jul. 8 at 4:10 PM

$PFE More downgrades please…

0 · Reply

DoubleUpwithChuck Jul. 8 at 4:05 PM

$ELTP I’ve been in penny stocks where it’s a 40 —60 gamble whether they even file at all nevertheless on time. THIS IS NOT ONE OF THOSE STOCKS. $ELTP ALWAYS ALWAYS ALWAYS files its financials and always files in a timely manner. They love talking to us and they even take our investor submitted questions. Just email Diane. All good news here and $40 Million in profits!!! And rising 😁🙌🚀 http://Elitepharmaceuticals.com $MRNA $PFE $GSK

0 · Reply

Pfizer price target lowered to $28 from $30 at JPMorgan

2026-07-07T15:54:25.000Z - 1 day ago

Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade

Jul 6, 2026, 10:00 AM EDT - 2 days ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

2026-07-06T09:50:29.000Z - 2 days ago

Pfizer downgraded to Hold from Buy at HSBC

Jun 29, 2026, 4:43 PM EDT - 8 days ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 9 days ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 13 days ago

Pfizer Declares Third-Quarter 2026 Dividend

2026-06-24T18:20:21.000Z - 13 days ago

Pfizer confirms FDA approval of Ibrance for HR+ metastatic breast cancer

Jun 24, 2026, 2:10 PM EDT - 13 days ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

2026-06-24T15:25:12.000Z - 14 days ago

FDA approves Pfizer’s Ibrance combo for metastatic breast cancer

Jun 24, 2026, 10:51 AM EDT - 14 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 15 days ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 15 days ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 15 days ago

Pfizer's experimental drug misses main goal of lung cancer trial

2026-06-22T20:33:17.000Z - 15 days ago

Pfizer says sigvotatug vedotin did not show big improvement in primary endpoint

Jun 22, 2026, 4:30 PM EDT - 15 days ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 15 days ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

2026-06-18T18:35:11.000Z - 19 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit

Jun 18, 2026, 6:52 AM EDT - 20 days ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 20 days ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 4 weeks ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 4 weeks ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 4 weeks ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 4 weeks ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 4 weeks ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 4 weeks ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 4 weeks ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 4 weeks ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 4 weeks ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 4 weeks ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 4 weeks ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 5 weeks ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 5 weeks ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 9:22 AM EDT - 5 weeks ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

May 30, 2026, 8:00 AM EDT - 5 weeks ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 5 weeks ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 5 weeks ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 5 weeks ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 5 weeks ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 5 weeks ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 7 weeks ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 7 weeks ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 7 weeks ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 18, 2026, 8:00 AM EDT - 7 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 7 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

May 13, 2026, 6:45 AM EDT - 2 months ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 12, 2026, 8:00 AM EDT - 2 months ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 2 months ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 2 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 2 months ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 2 months ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 2 months ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 2 months ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 2 months ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 2 months ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 2 months ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 2 months ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

WalterSmith922 Jul. 8 at 5:48 PM

0 · Reply

DoubleUpwithChuck Jul. 8 at 5:48 PM

$ELTP $GSK $MRNA $PFE https://elitepharma.com/ the correct website

0 · Reply

Micheal_Pothead Jul. 8 at 5:36 PM

$PFE just go red man..

0 · Reply

CapitalismUSA Jul. 8 at 5:36 PM

$ABUS $PFE Hey Pfizer crooks ……

0 · Reply

Micheal_Pothead Jul. 8 at 5:33 PM

$PFE the Nasdaq is green… Lol..

0 · Reply

TheUnmaker Jul. 8 at 5:25 PM

$TNXP $SLS $PFE $GALT

1 · Reply

DivvyInvestor Jul. 8 at 5:06 PM

$PFE I Wanna Get Back In PFE.. How Bout $23.70 Again ? There...........

0 · Reply

DivvyInvestor Jul. 8 at 5:04 PM

$PFE I'd LOVE To Re Establish My Position Of 52,000 Shares Again At $23.70, Where I Bought, Monday. SO PFE...........

0 · Reply

breakawayrider Jul. 8 at 4:10 PM

$PFE More downgrades please…

0 · Reply

DoubleUpwithChuck Jul. 8 at 4:05 PM

0 · Reply

QuietlyAccumulating Jul. 8 at 4:04 PM

$PFE $SURNF Good play for Pfizer?

0 · Reply

GeniusintheFlesh Jul. 8 at 3:40 PM

$ELTP $PFE $JNJ $MRNA $GME ELTP is an Epstein-Trump pe do supporter stock? That is highly disappointing. Don't get suckered by this, the pe do prez just cashed billions in crypto from his supporters. Don't become another one of this adjucated ra pists victims!

0 · Reply

IndigoDrift83 Jul. 8 at 3:36 PM

Hump Day gave traders a little fear. I saw an opportunity. I bought the dip in $NRED.CSE ,and I’m not changing my thesis because of one red session. Copper remains essential. AI development keeps increasing electricity demand. Critical minerals are becoming a national-security issue. MetalCore gives NovaRed a technology angle on top of the underlying resource story. That combination is exactly why I’m still holding. The chart can shake. The story remains alive. $GLW $PATH $PFE

0 · Reply

DivvyInvestor Jul. 8 at 3:35 PM

$PFE JUST SOLD MY 52,000 SHARES BOUGHT MONDAY AT $23.70. $31,000 PROFIT GLTA

1 · Reply

Typecheck Jul. 8 at 3:27 PM

$PFE this is the adult diaper of stock market. It only gets attention when shit is about the hit the fan.

2 · Reply

scarlettdraws Jul. 8 at 3:23 PM

I didn't stay through the development phase just to sell as MetalCore moves closer to execution. Yesterday's update strengthened my investment thesis, so I'm staying patient and holding. $NREDF $NRED.CSE $INTC $NOK $PFE NFA

0 · Reply